{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T14:27:01Z","timestamp":1784903221280,"version":"3.55.0"},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2016,11,3]],"date-time":"2016-11-03T00:00:00Z","timestamp":1478131200000},"content-version":"vor","delay-in-days":672,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Background. \u2003Annual influenza epidemics are responsible for substantial morbidity and mortality. The use of immunomodulatory agents such as statins to target host inflammatory responses in influenza virus infection has been suggested as an adjunct treatment, especially during pandemics, when antiviral quantities are limited or vaccine production can be delayed.<\/jats:p>\n               <jats:p>Methods. \u2003We used population-based, influenza hospitalization surveillance data, propensity score-matched analysis, and Cox regression to determine whether there was an association between mortality (within 30 days of a positive influenza test) and statin treatment among hospitalized cohorts from 2 influenza seasons (October 1, 2007 to April 30, 2008 and September 1, 2009 to April 31, 2010).<\/jats:p>\n               <jats:p>Results. \u2003Hazard ratios for death within the 30-day follow-up period were 0.41 (95% confidence interval [CI], .25\u2013.68) for a matched sample from the 2007\u20132008 season and 0.77 (95% CI, .43\u20131.36) for a matched sample from the 2009 pandemic.<\/jats:p>\n               <jats:p>Conclusions. \u2003The analysis suggests a protective effect against death from influenza among patients hospitalized in 2007\u20132008 but not during the pandemic. Sensitivity analysis indicates the findings for 2007\u20132008 may be influenced by unmeasured confounders. This analysis does not support using statins as an adjunct treatment for preventing death among persons hospitalized for influenza.<\/jats:p>","DOI":"10.1093\/ofid\/ofv028","type":"journal-article","created":{"date-parts":[[2015,3,5]],"date-time":"2015-03-05T02:03:24Z","timestamp":1425521004000},"source":"Crossref","is-referenced-by-count":24,"title":["Statin Treatment and Mortality: Propensity Score-Matched Analyses of 2007\u20132008 and 2009\u20132010 Laboratory-Confirmed Influenza Hospitalizations"],"prefix":"10.1093","volume":"2","author":[{"given":"Matthew R.","family":"Laidler","sequence":"first","affiliation":[{"name":"Oregon Public Health Division, OregonHealth Authority, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Thomas","sequence":"additional","affiliation":[{"name":"Oregon Public Health Division, OregonHealth Authority, Portland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan","family":"Baumbach","sequence":"additional","affiliation":[{"name":"New Mexico Department of Health, Santa Fe"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pam Daily","family":"Kirley","sequence":"additional","affiliation":[{"name":"California Emerging Infections Program, Oakland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Meek","sequence":"additional","affiliation":[{"name":"Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Aragon","sequence":"additional","affiliation":[{"name":"Colorado Department of Public Health and Environment, Denver"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Morin","sequence":"additional","affiliation":[{"name":"Minnesota Department of Health, St. Paul"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A.","family":"Ryan","sequence":"additional","affiliation":[{"name":"Maryland Department of Health and Mental Hygiene, Baltimore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Schaffner","sequence":"additional","affiliation":[{"name":"Vanderbilt University School of Medicine, Nashville, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley M.","family":"Zansky","sequence":"additional","affiliation":[{"name":"Emerging Infections Program New York State Department of Health, Albany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra S.","family":"Chaves","sequence":"additional","affiliation":[{"name":"Influenza Division, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,3,4]]},"reference":[{"key":"2020081006372465600_OFV028C1","doi-asserted-by":"crossref","first-page":"e66312","DOI":"10.1371\/journal.pone.0066312","article-title":"Influenza illness and hospitalizations averted by influenza vaccination in the United States, 2005\u20132011","volume":"8","author":"Kostova","year":"2013","journal-title":"PloS One"},{"key":"2020081006372465600_OFV028C2","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/jama.292.11.1333","article-title":"Influenza-associated hospitalizations in the United States","volume":"292","author":"Thompson","year":"2004","journal-title":"JAMA"},{"key":"2020081006372465600_OFV028C3","first-page":"1057","article-title":"Estimates of deaths associated with seasonal influenza --- United States, 1976\u20132007","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2020081006372465600_OFV028C4","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/aje\/kwh227","article-title":"Influenza and the winter increase in mortality in the United States, 1959\u20131999","volume":"160","author":"Reichert","year":"2004","journal-title":"Am J Epidemiol"},{"key":"2020081006372465600_OFV028C5","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMoa0906453","article-title":"Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus","volume":"361","author":"Hancock","year":"2009","journal-title":"N Engl J Med"},{"key":"2020081006372465600_OFV028C6","doi-asserted-by":"crossref","first-page":"e1001558","DOI":"10.1371\/journal.pmed.1001558","article-title":"Global mortality estimates for the 2009 influenza pandemic from the GLaMOR project: a modeling study","volume":"10","author":"Simonsen","year":"2013","journal-title":"PLoS Med"},{"key":"2020081006372465600_OFV028C7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/cid\/cir400","article-title":"Oseltamivir and risk of lower respiratory tract complications in patients with flu symptoms: a meta-analysis of eleven randomized clinical trials","volume":"53","author":"Hernan","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2020081006372465600_OFV028C8","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1136\/thx.2009.130799","article-title":"Outcomes of adults hospitalised with severe influenza","volume":"65","author":"Lee","year":"2010","journal-title":"Thorax"},{"key":"2020081006372465600_OFV028C9","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1086\/523584","article-title":"Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada","volume":"45","author":"McGeer","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2020081006372465600_OFV028C10","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1093\/cid\/cis636","article-title":"Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09","volume":"55","author":"Louie","year":"2012","journal-title":"Clin Infect Dis"},{"key":"2020081006372465600_OFV028C11","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/infdis\/jis726","article-title":"Impact of neuraminidase inhibitor treatment on outcomes of public health importance during the 2009\u20132010 influenza A(H1N1) pandemic: a systematic review and meta-analysis in hospitalized patients","volume":"207","author":"Muthuri","year":"2013","journal-title":"J Infect Dis"},{"key":"2020081006372465600_OFV028C12","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1093\/infdis\/jit316","article-title":"Patients hospitalized with laboratory-confirmed influenza during the 2010\u20132011 influenza season: exploring disease severity by virus type and subtype","volume":"208","author":"Chaves","year":"2013","journal-title":"J Infect Dis"},{"key":"2020081006372465600_OFV028C13","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1086\/505116","article-title":"Pandemic influenza: a potential role for statins in treatment and prophylaxis","volume":"43","author":"Fedson","year":"2006","journal-title":"Clin Infect Dis"},{"key":"2020081006372465600_OFV028C14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/cid\/cit695","article-title":"How will physicians respond to the next influenza pandemic?","volume":"58","author":"Fedson","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2020081006372465600_OFV028C15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/bja\/ael358","article-title":"Beneficial effects of statins on the microcirculation during sepsis: the role of nitric oxide","volume":"98","author":"McGown","year":"2007","journal-title":"Br J Anaesth"},{"key":"2020081006372465600_OFV028C16","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/01.ccx.0000235207.00322.96","article-title":"Statins in the intensive care unit","volume":"12","author":"Merx","year":"2006","journal-title":"Curr Opin Crit Care"},{"key":"2020081006372465600_OFV028C17","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/cc3972","article-title":"Do statins have a role in preventing or treating sepsis?","volume":"10","author":"Novack","year":"2006","journal-title":"Crit Care"},{"key":"2020081006372465600_OFV028C18","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/01.CCM.0000253397.42079.D5","article-title":"The effect of statin therapy on infection-related mortality in patients with atherosclerotic diseases","volume":"35","author":"Almog","year":"2007","journal-title":"Crit Care Med"},{"key":"2020081006372465600_OFV028C19","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1161\/01.CIR.0000138932.17956.F1","article-title":"Prior statin therapy is associated with a decreased rate of severe sepsis","volume":"110","author":"Almog","year":"2004","journal-title":"Circulation"},{"key":"2020081006372465600_OFV028C20","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(06)68041-0","article-title":"Statins and sepsis in patients with cardiovascular disease: a population-based cohort analysis","volume":"367","author":"Hackam","year":"2006","journal-title":"Lancet"},{"key":"2020081006372465600_OFV028C21","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1001\/archinternmed.2009.286","article-title":"Statins for the prevention and treatment of infections: a systematic review and meta-analysis","volume":"169","author":"Tleyjeh","year":"2009","journal-title":"Arch Intern Med"},{"key":"2020081006372465600_OFV028C22","doi-asserted-by":"crossref","first-page":"e18120","DOI":"10.1371\/journal.pone.0018120","article-title":"Pre-admission statin use and in-hospital severity of 2009 pandemic influenza A(H1N1) disease","volume":"6","author":"Brett","year":"2011","journal-title":"PloS One"},{"key":"2020081006372465600_OFV028C23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/infdis\/jir695","article-title":"Association between use of statins and mortality among patients hospitalized with laboratory-confirmed influenza virus infections: a multistate study","volume":"205","author":"Vandermeer","year":"2012","journal-title":"J Infect Dis"},{"key":"2020081006372465600_OFV028C24","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1378\/chest.06-1997","article-title":"Influenza and COPD mortality protection as pleiotropic, dose-dependent effects of statins","volume":"131","author":"Frost","year":"2007","journal-title":"Chest"},{"key":"2020081006372465600_OFV028C25","doi-asserted-by":"crossref","first-page":"e8087","DOI":"10.1371\/journal.pone.0008087","article-title":"Influenza morbidity and mortality in elderly patients receiving statins: a cohort study","volume":"4","author":"Kwong","year":"2009","journal-title":"PloS One"},{"key":"2020081006372465600_OFV028C26","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"2020081006372465600_OFV028C27","article-title":"Performing a 1:N case-control match on propensity score","author":"Parsons","year":"2004"},{"key":"2020081006372465600_OFV028C28","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4757-3692-2","volume-title":"Observational Studies","author":"Rosenbaum","year":"2002","edition":"2nd ed"},{"key":"2020081006372465600_OFV028C29","article-title":"OpenEpi: Open Source Epidemiologic Statistics for Public Health","author":"Dean"},{"key":"2020081006372465600_OFV028C30","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/82219","article-title":"Statins as a newly recognized type of immunomodulator","volume":"6","author":"Kwak","year":"2000","journal-title":"Nat Med"},{"key":"2020081006372465600_OFV028C31","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jinf.2011.01.014","article-title":"Effect of immunomodulatory therapies in patients with pandemic influenza A (H1N1) 2009 complicated by pneumonia","volume":"62","author":"Viasus","year":"2011","journal-title":"J Infect"},{"key":"2020081006372465600_OFV028C32","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1001\/jama.2013.280031","article-title":"Effect of statin therapy on mortality in patients with ventilator-associated pneumonia: a randomized clinical trial","volume":"310","author":"Papazian","year":"2013","journal-title":"JAMA"},{"key":"2020081006372465600_OFV028C33","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1401520","article-title":"Rosuvastatin for sepsis-associated acute respiratory distress syndrome","volume":"370","author":"National Heart, Lung, and Blood Institute ARDS Clinical Trials Network","year":"2014","journal-title":"N Engl J Med"},{"key":"2020081006372465600_OFV028C34","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.3892\/mmr.2014.2076","article-title":"Protective effect of fluvastatin on influenza virus infection","volume":"9","author":"Peng","year":"2014","journal-title":"Mol Med Rep"},{"key":"2020081006372465600_OFV028C35","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/infdis\/jis344","article-title":"Association between statins and mortality","volume":"206","author":"Jackson","year":"2012","journal-title":"J Infect Dis"},{"key":"2020081006372465600_OFV028C36","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/aje\/kwm070","article-title":"Adherence to lipid-lowering therapy and the use of preventive health services: an investigation of the healthy user effect","volume":"166","author":"Brookhart","year":"2007","journal-title":"Am J Epidemiol"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/2\/1\/ofv028\/33620873\/ofv028.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ofid\/article-pdf\/2\/1\/ofv028\/33620873\/ofv028.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T10:46:44Z","timestamp":1597056404000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofv028\/2337978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofv028","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015]]},"published":{"date-parts":[[2015,1,1]]},"article-number":"ofv028"}}